Document is current
Any future updates will be listed below
-
Authors
Moreau, Philippe https://orcid.org/0000-0003-1780-8746
Hulin, Cyrille https://orcid.org/0000-0002-3749-5161
Talbot, Alexis https://orcid.org/0000-0001-6734-413X
Demarquette, Hélène
Caillot, Léo
Chalopin, Thomas https://orcid.org/0000-0002-9833-3115
Bobin, Arthur
Manier, Salomon
Leleu, Xavier https://orcid.org/0000-0002-9822-4170
Karlin, Lionel
Caillot, Denis https://orcid.org/0009-0009-6985-5609
Sonntag, Cécile
Feugier, Pierre
Roussel, Murielle
Gounot, Romain
Macro, Margaret
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Garderet, Laurent
Tiab, Mourab
Orsini-Piocelle, Frédérique
Vincent, Laure https://orcid.org/0000-0001-5904-1286
Meuleman, Nathalie
Fontan, Jean
Montes, Lidia
Vekemans, Marie-Christiane
Escoffre-Barbe, Martine
Eveillard, Jean-Richard
Schiano de Colella, Jean-Marc
Lambert, Jérôme
Mary, Jean-Yves
Fermand, Jean-Paul
Arnulf, Bertrand
Corre, Jill https://orcid.org/0000-0003-1580-6106
Avet-Loiseau, Hervé
Facon, Thierry
Harousseau, Jean-Luc
Touzeau, Cyrille https://orcid.org/0000-0003-0275-2575
Perrot, Aurore https://orcid.org/0000-0003-0131-8689
- License Information
-
More Information
Article History
Received: 7 July 2025
Revised: 2 September 2025
Accepted: 23 September 2025
First Online: 24 October 2025
Competing interests
: PM reports honoraria and advisory boards: Janssen, BMS, Amgen, Takeda, GSK, Sanofi, Pfizer, Abbvie. CH reports honoraria and advisory boards: Janssen, Sanofi, Amgen, Abbvie, BMS, Stemline Menarini. AT reports consulting: Amgen, GSK, Janssen, Pfizer, Sanofi, Stemline Menarini. HD reports consulting: Janssen, Pfizer, Sanofi, Stemline Menarini, BMS, Abbvie. TC reports consulting: Janssen, GSK, Pfizer, BMS, Stemline Menarini, Grifols, Sanofi. SM reports consulting: AbbVie, Adaptive Biotechnology, Amgen, BMS, GSK, Janssen, Kite, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda. XL reports honoraria and advisory boards: Janssen, Amgen, Abbvie, Regeneron, BMS, GSK, Roche, Takeda, Novartis, Sanofi, Pfizer, Oncopeptide, Ichnos. LK reports honoraria and advisory boards: Amgen, Celgene-BMS, Janssen, Takeda, Sanofi, Pfizer, Abbvie. DC reports advisory boards: BMS. CS reports honoraria and advisory boards: Janssen, Pfizer, Amgen, Sanofi, Takeda, GSK. PG reports consulting: AstraZeneca, Roche, Gilead, Janssen, BeiGene, Lilly. MR reports honoraria and advisory boards: Janssen, Amgen, GSK, Pfizer. MMa reports honoraria and advisory boards: Amgen, BMS, GSK, Janssen, Sanofi, Takeda. MMo reports honoraria and advisory boards: Abbvie, Adaptive Biotechnologies, Amgen, Astellas, BMS, GSK, Janssen, Jazz, Novartis, Pfizer, Sanofi, Stemline Menarini, Takeda. LG reports honoraria and advisory boards: Sanofi, Pfizer, BMS, Janssen. FOP reports honoraria: Sanofi. LV reports honorarias and advisory boards: Janssen, BMS, Takeda, Sanofi, Pfizer. NM reports honoraria and advisory boards from Janssen. MCV reports honoraria and advisory boards: Amgen, GSK, BMS, Stemline Menarini, Pfizer, Janssen, Sanofi, Takeda. JMSC reports honoraria and advisory boards: Janssen, Sanofi, GSK, Abbvie, Pfizer, Amgen. BA reports honoraria and advisory boards: Janssen, BMS, Amgen, Sanofi. JC reports honoraria and advisory boards: Janssen, Sanofi, Bristol Myers Squibb, Pfizer and Adaptive. CT reports honoraria and advisory boards: Janssen, Pfizer, Amgen, Sanofi, Takeda, GSK, Abbvie, Menarini, BMS. A.P. reports honoraria and advisory boards: AbbVie, Amgen, BMS, GSK, Janssen, Pfizer, Sanofi, Takeda. The rest of the authors have no conflicts of interest.
